Federation des caisses Desjardins du Quebec’s Filana Therapeutics FLNA Stock Holding History
Bought
Maintained
Sold
Other funds holding FLNA
VCM
GC
Federation des caisses Desjardins du Quebec's FLNA Position: Q1 2026 in Review
Federation des caisses Desjardins du Quebec held its Filana Therapeutics (FLNA) position steady in Q1 2026 at 4,695 shares worth $7.93K. The position accounts for ﹤0.01% of the portfolio, ranked #2390.
Federation des caisses Desjardins du Quebec first reported a position in FLNA in Q1 2021 and has held it in 21 quarters since. The position peaked at $138K in Q3 2024. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.
- Federation des caisses Desjardins du Quebec held 4,695 shares of Filana Therapeutics worth $7.93K as of Q1 2026.
- Federation des caisses Desjardins du Quebec left its Filana Therapeutics share count unchanged in Q1 2026.
- Filana Therapeutics made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q1 2026, its #2390 holding.
- Federation des caisses Desjardins du Quebec first reported a position in Filana Therapeutics in Q1 2021 and has held it in 21 quarters since.
- Federation des caisses Desjardins du Quebec's Filana Therapeutics position peaked at $138K in Q3 2024.
- 101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.
Based on Federation des caisses Desjardins du Quebec's 13F filing for Q1 2026, filed 14 May 2026.